Safety and efficacy of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma: Results from the phase 1b MagnetisMM-30 trialAttaya Suvannasankha, Alexander M. Lesokhin, Patrick J. Mueller et al.|Blood|2025Cited by 6